Wei Tan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Wei Tan has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
Fangfang Dai
Department of Obstetrics and Gynecology Renmin Hospital of Wuhan University Wuhan China
3 shared publicationsZhimin Deng
Department of Obstetrics and Gynecology Renmin Hospital of Wuhan University Wuhan China
3 shared publicationsMengqin Yuan
Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, China
2 shared publicationsShiyi Liu
Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, China
2 shared publicationsWei Hu
Department of Obstetrics and Gynecology Ultrasound, Renmin Hospital of Wuhan University, Wuhan, China
2 shared publications- Anling Luo
School of Basic Medicine, Jinan University, Guangzhou, China
1 shared publication
Latest Publications
- 4 August 2026
- Published by Wiley in Journal of Cutaneous Pathology
Lesions Reported as Plaque‐Like CD34 ‐Positive Dermal Fibroma Reveal Two Reproducible Clinicopathologic Patterns: Two Cases and Literature Review
Plaque‐like CD34‐positive dermal fibroma (PDF), which historically overlaps with medallion‐like dermal dendrocyte hamartoma (MDDH), is a rare benign CD34‐positive spindle‐cell lesion with highly variable clinicopathologic descriptions. We analyzed two adult‐onset cases and reviewed the published literature to determine whether reported PDF/MDDH lesions cluster into reproducible clinicopathologic patterns. Our literature review comprises 25 cases. Comparative analyses revealed marked differences in age at onset, lesion size, anatomic distribution, depth of involvement, papillary dermis sparing, subcutaneous extension, and epidermal response. One pattern was characterized by early‐onset, larger plaque‐like lesions on the trunk or neck, with deep dermal to subcutaneous spindle‐cell proliferation and frequent epidermal atrophy (early‐onset deep pattern). The second pattern was characterized by adult‐onset, small papules or papuloplaques, predominantly on the extremities, featuring upper reticular dermal spindle‐cell proliferation, papillary dermis sparing, elongated rete ridges, and a perpendicular‐to‐horizontal spindle‐cell arrangement (adult‐onset superficial pattern). All lesions showed diffuse CD34 positivity. Lesions currently reported under the PDF/MDDH umbrella appear to encompass two reproducible clinicopathologic patterns. Recognizing these patterns may improve diagnostic accuracy and facilitate the distinction of these lesions from dermatofibrosarcoma protuberans and other superficial CD34‐positive spindle‐cell proliferations.
- 4 August 2026
- Published by Wiley in Journal of Cutaneous Pathology
Lesions Reported as Plaque‐Like CD34 ‐Positive Dermal Fibroma Reveal Two Reproducible Clinicopathologic Patterns: Two Cases and Literature Review
Plaque‐like CD34‐positive dermal fibroma (PDF), which historically overlaps with medallion‐like dermal dendrocyte hamartoma (MDDH), is a rare benign CD34‐positive spindle‐cell lesion with highly variable clinicopathologic descriptions. We analyzed two adult‐onset cases and reviewed the published literature to determine whether reported PDF/MDDH lesions cluster into reproducible clinicopathologic patterns. Our literature review comprises 25 cases. Comparative analyses revealed marked differences in age at onset, lesion size, anatomic distribution, depth of involvement, papillary dermis sparing, subcutaneous extension, and epidermal response. One pattern was characterized by early‐onset, larger plaque‐like lesions on the trunk or neck, with deep dermal to subcutaneous spindle‐cell proliferation and frequent epidermal atrophy (early‐onset deep pattern). The second pattern was characterized by adult‐onset, small papules or papuloplaques, predominantly on the extremities, featuring upper reticular dermal spindle‐cell proliferation, papillary dermis sparing, elongated rete ridges, and a perpendicular‐to‐horizontal spindle‐cell arrangement (adult‐onset superficial pattern). All lesions showed diffuse CD34 positivity. Lesions currently reported under the PDF/MDDH umbrella appear to encompass two reproducible clinicopathologic patterns. Recognizing these patterns may improve diagnostic accuracy and facilitate the distinction of these lesions from dermatofibrosarcoma protuberans and other superficial CD34‐positive spindle‐cell proliferations.
- Open Access
- 18 May 2023
- Published by Wiley in Cancer Medicine
- Vol. 12 (13) , 14833-14850
Pan‐cancer analysis of oncogenic role of insulin‐like growth factor‐binding proteins and validation in ovarian cancer
Background: Numerous studies have shown that the insulin‐like growth factor (IGF) pathway is highly associated with tumor initial and progression in several tumors. However, compared with IGF1/1R and IGF2/2R, insufficient studies have focused on IGF‐binding proteins (IGFBPs).Methods: The GDC TCGA and GTEx data of 33 cancers, TCGA pan‐cancer immune phenotypes, tumor mutation burdens, and the copy number alterations of IGFBPs were extracted. Next, the prognostic value of IGFBPs was analyzed based on a univariate Cox analysis. Additionally, the ESTIMATE algorithm was used to calculate stromal and immune scores and tumor purity, and the CIBERSORT algorithm was used to estimate tumor‐infiltrating immunocyte levels. Ultimately, the correlation between IGFBP expression and cancer hallmark pathways was estimated with a Spearman analysis.Results: The expression of IGFBPs was differentially expressed and correlated with prognosis in specific cancers. IGFBPs may operate as biological markers for carcinogenesis and progression and as prognostic biomarkers. Additionally, IGFBP5 has been proved that promotes the invasion and migration of ovarian cancer.Conclusions: In general, IGFBPs can serve as predictable biomarkers and potential therapeutic targets for specific tumors. Our results could provide underlying targets for the design of laboratory experiments to elucidate the mechanism of IGFBPs in cancers and identify IGFBP5 as a prognostic factor in ovarian cancers.
- 18 May 2023
- Published by Wiley in Cancer Medicine
- Vol. 12 (13) , 14833-14850
Open AccessPan‐cancer analysis of oncogenic role of insulin‐like growth factor‐binding proteins and validation in ovarian cancer
Background: Numerous studies have shown that the insulin‐like growth factor (IGF) pathway is highly associated with tumor initial and progression in several tumors. However, compared with IGF1/1R and IGF2/2R, insufficient studies have focused on IGF‐binding proteins (IGFBPs).Methods: The GDC TCGA and GTEx data of 33 cancers, TCGA pan‐cancer immune phenotypes, tumor mutation burdens, and the copy number alterations of IGFBPs were extracted. Next, the prognostic value of IGFBPs was analyzed based on a univariate Cox analysis. Additionally, the ESTIMATE algorithm was used to calculate stromal and immune scores and tumor purity, and the CIBERSORT algorithm was used to estimate tumor‐infiltrating immunocyte levels. Ultimately, the correlation between IGFBP expression and cancer hallmark pathways was estimated with a Spearman analysis.Results: The expression of IGFBPs was differentially expressed and correlated with prognosis in specific cancers. IGFBPs may operate as biological markers for carcinogenesis and progression and as prognostic biomarkers. Additionally, IGFBP5 has been proved that promotes the invasion and migration of ovarian cancer.Conclusions: In general, IGFBPs can serve as predictable biomarkers and potential therapeutic targets for specific tumors. Our results could provide underlying targets for the design of laboratory experiments to elucidate the mechanism of IGFBPs in cancers and identify IGFBP5 as a prognostic factor in ovarian cancers.
- 1 September 2022
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 149 (2) , 593-608
Gene signature of m6A-related targets to predict prognosis and immunotherapy response in ovarian cancer
Purpose The aim of the study was to construct a risk score model based on m6A-related targets to predict overall survival and immunotherapy response in ovarian cancer. Methods The gene expression profiles of 24 m6A regulators were extracted. Survival analysis screened 9 prognostic m6A regulators. Next, consensus clustering analysis was applied to identify clusters of ovarian cancer patients. Furthermore, 47 phenotype-related differentially expressed genes, strongly correlated with 9 prognostic m6A regulators, were screened and subjected to univariate and the least absolute shrinkage and selection operator (LASSO) Cox regression. Ultimately, a nomogram was constructed which presented a strong ability to predict overall survival in ovarian cancer. Results CBLL1, FTO, HNRNPC, METTL3, METTL14, WTAP, ZC3H13, RBM15B and YTHDC2 were associated with worse overall survival (OS) in ovarian cancer. Three m6A clusters were identified, which were highly consistent with the three immune phenotypes. What is more, a risk model based on seven m6A-related targets was constructed with distinct prognosis. In addition, the low-risk group is the best candidate population for immunotherapy. Conclusion We comprehensively analyzed the m6A modification landscape of ovarian cancer and detected seven m6A-related targets as an independent prognostic biomarker for predicting survival. Furthermore, we divided patients into high- and low-risk groups with distinct prognosis and select the optimum population which may benefit from immunotherapy and constructed a nomogram to precisely predict ovarian cancer patients’ survival time and visualize the prediction results.
- 1 September 2022
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 149 (2) , 593-608
Gene signature of m6A-related targets to predict prognosis and immunotherapy response in ovarian cancer
Purpose The aim of the study was to construct a risk score model based on m6A-related targets to predict overall survival and immunotherapy response in ovarian cancer. Methods The gene expression profiles of 24 m6A regulators were extracted. Survival analysis screened 9 prognostic m6A regulators. Next, consensus clustering analysis was applied to identify clusters of ovarian cancer patients. Furthermore, 47 phenotype-related differentially expressed genes, strongly correlated with 9 prognostic m6A regulators, were screened and subjected to univariate and the least absolute shrinkage and selection operator (LASSO) Cox regression. Ultimately, a nomogram was constructed which presented a strong ability to predict overall survival in ovarian cancer. Results CBLL1, FTO, HNRNPC, METTL3, METTL14, WTAP, ZC3H13, RBM15B and YTHDC2 were associated with worse overall survival (OS) in ovarian cancer. Three m6A clusters were identified, which were highly consistent with the three immune phenotypes. What is more, a risk model based on seven m6A-related targets was constructed with distinct prognosis. In addition, the low-risk group is the best candidate population for immunotherapy. Conclusion We comprehensively analyzed the m6A modification landscape of ovarian cancer and detected seven m6A-related targets as an independent prognostic biomarker for predicting survival. Furthermore, we divided patients into high- and low-risk groups with distinct prognosis and select the optimum population which may benefit from immunotherapy and constructed a nomogram to precisely predict ovarian cancer patients’ survival time and visualize the prediction results.
- Open Access
- 11 May 2022
- Published by Springer Nature in Research Square
Gene signature of m6A-related targets to predict prognosis and immunotherapy response in ovarian cancer
Purpose: The aim of the study was to construct a risk score model based on m6A-related targets to predict overall survival and immunotherapy response in ovarian cancer.Methods: The gene expression profiles of 24 m6A regulators were extracted. Survival analysis screened 9 prognostic m6A regulators. Next, consensus clustering analysis was applied to identify clusters of ovarian cancer patients. Furthermore, 47 phenotype-related differentially expressed genes, strongly correlated with 9 prognostic m6A regulators, were screened and subjected to univariate and the least absolute shrinkage and selection operator (LASSO) cox regression. Ultimately, a nomogram was constructed which presented a strong ability to predict overall survival in ovarian cancer.Results: CBLL1, FTO, HNRNPC, METTL3, METTL14, WTAP, ZC3H13, RBM15B and YTHDC2 were associated with worse overall survival (OS) in ovarian cancer. Three m6A clusters were identified, which were highly consistent with the three immune phenotypes. What’s more, a risk model based on seven m6A-related targets was constructed with distinct prognosis. And the low-risk group are the best candidate population for immunotherapy. Conclusions: We comprehensively analyzed the m6A modification landscape of ovarian cancer and detected seven m6A-related targets as an independent prognostic biomarker for predicting survival. Furthermore, we divided patients into high- and low- risk groups with distinct prognosis and select the optimum population which may benefit from immunotherapy and constructed a nomogram to precisely predict ovarian cancer patients’ survival time and visualize the prediction results.
- 11 May 2022
- Published by Springer Nature in Research Square
Open AccessGene signature of m6A-related targets to predict prognosis and immunotherapy response in ovarian cancer
Purpose: The aim of the study was to construct a risk score model based on m6A-related targets to predict overall survival and immunotherapy response in ovarian cancer.Methods: The gene expression profiles of 24 m6A regulators were extracted. Survival analysis screened 9 prognostic m6A regulators. Next, consensus clustering analysis was applied to identify clusters of ovarian cancer patients. Furthermore, 47 phenotype-related differentially expressed genes, strongly correlated with 9 prognostic m6A regulators, were screened and subjected to univariate and the least absolute shrinkage and selection operator (LASSO) cox regression. Ultimately, a nomogram was constructed which presented a strong ability to predict overall survival in ovarian cancer.Results: CBLL1, FTO, HNRNPC, METTL3, METTL14, WTAP, ZC3H13, RBM15B and YTHDC2 were associated with worse overall survival (OS) in ovarian cancer. Three m6A clusters were identified, which were highly consistent with the three immune phenotypes. What’s more, a risk model based on seven m6A-related targets was constructed with distinct prognosis. And the low-risk group are the best candidate population for immunotherapy. Conclusions: We comprehensively analyzed the m6A modification landscape of ovarian cancer and detected seven m6A-related targets as an independent prognostic biomarker for predicting survival. Furthermore, we divided patients into high- and low- risk groups with distinct prognosis and select the optimum population which may benefit from immunotherapy and constructed a nomogram to precisely predict ovarian cancer patients’ survival time and visualize the prediction results.
- 1 September 2021
- Published by Elsevier in Acta Histochemica
- Vol. 123 (6) , 151752
Circular RNA EGLN3 silencing represses renal cell carcinoma progression through the miR-1224-3p/HMGXB3 axis
- 1 September 2021
- Published by Elsevier in Acta Histochemica
- Vol. 123 (6) , 151752
Circular RNA EGLN3 silencing represses renal cell carcinoma progression through the miR-1224-3p/HMGXB3 axis
- Open Access
- 23 January 2020
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 13, 1447
Associations Between Colonic Motor Patterns and Autonomic Nervous System Activity Assessed by High-Resolution Manometry and Concurrent Heart Rate Variability
Abnormal colonic motility may be associated with dysfunction of the autonomic nervous system (ANS). Our aim was to evaluate if associations between colonic motor patterns and autonomic neural activity could be demonstrated by assessing changes in heart rate variability (HRV) in healthy volunteers. A total of 145 colonic motor patterns were assessed in 11 healthy volunteers by High-Resolution Colonic Manometry (HRCM) using an 84-channel water-perfused catheter. Motor patterns were evoked by balloon distention, a meal and luminal bisacodyl. The electrocardiogram (ECG) and cardiac impedance were assessed during colonic manometry. Respiratory sinus arrhythmia (RSA) and root mean square of successive differences of beat-to-beat intervals (RMSSD) served as measures of parasympathetic reactivity while the Baevsky’s Stress Index (SI) and the pre-ejection period (PEP) were used as measures of sympathetic reactivity. Taking all motor patterns into account, our data show that colonic motor patterns are accompanied by increased parasympathetic activity and decreased sympathetic activity that may occur without eliciting a significant change in heart rate. Motor Complexes (more than one motor pattern occurring in close proximity), High-Amplitude Propagating Pressure Waves followed by Simultaneous Pressure Waves (HAPW-SPWs) and HAPWs without SPWs are all associated with an increase in RSA and a decrease in SI. Hence RSA and SI may best reflect autonomic activity in the colon during these motor patterns as compared to RMSSD and PEP. SI and PEP do not measure identical sympathetic reactivity. The SPW, which is a very low amplitude pressure wave, did not significantly change the autonomic measures employed here. In conclusion, colonic motor patterns are associated with activity in the ANS which is reflected in autonomic measures of heart rate variability. These autonomic measures may serve as proxies for autonomic neural dysfunction in patients with colonic dysmotility.
- 23 January 2020
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 13, 1447
Open AccessAssociations Between Colonic Motor Patterns and Autonomic Nervous System Activity Assessed by High-Resolution Manometry and Concurrent Heart Rate Variability
Abnormal colonic motility may be associated with dysfunction of the autonomic nervous system (ANS). Our aim was to evaluate if associations between colonic motor patterns and autonomic neural activity could be demonstrated by assessing changes in heart rate variability (HRV) in healthy volunteers. A total of 145 colonic motor patterns were assessed in 11 healthy volunteers by High-Resolution Colonic Manometry (HRCM) using an 84-channel water-perfused catheter. Motor patterns were evoked by balloon distention, a meal and luminal bisacodyl. The electrocardiogram (ECG) and cardiac impedance were assessed during colonic manometry. Respiratory sinus arrhythmia (RSA) and root mean square of successive differences of beat-to-beat intervals (RMSSD) served as measures of parasympathetic reactivity while the Baevsky’s Stress Index (SI) and the pre-ejection period (PEP) were used as measures of sympathetic reactivity. Taking all motor patterns into account, our data show that colonic motor patterns are accompanied by increased parasympathetic activity and decreased sympathetic activity that may occur without eliciting a significant change in heart rate. Motor Complexes (more than one motor pattern occurring in close proximity), High-Amplitude Propagating Pressure Waves followed by Simultaneous Pressure Waves (HAPW-SPWs) and HAPWs without SPWs are all associated with an increase in RSA and a decrease in SI. Hence RSA and SI may best reflect autonomic activity in the colon during these motor patterns as compared to RMSSD and PEP. SI and PEP do not measure identical sympathetic reactivity. The SPW, which is a very low amplitude pressure wave, did not significantly change the autonomic measures employed here. In conclusion, colonic motor patterns are associated with activity in the ANS which is reflected in autonomic measures of heart rate variability. These autonomic measures may serve as proxies for autonomic neural dysfunction in patients with colonic dysmotility.
- Open Access
- 1 January 2020
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2020 (1) , 2953502
Exosomal MicroRNA Expression Profiling Analysis of the Effects of Lycium Barbarum Polysaccharide on Gestational Diabetes Mellitus Mice
Objective. Gestational diabetes mellitus (GDM) is a pathological condition, affecting an increasing number of pregnant women worldwide. Safe and effective treatment for GDM is very important for the public health. In this study, we utilized a high‐fat diet‐induced GDM model to evaluate the effects of LBP on GDM and examined the changes of exosomal microRNA expression profiling to decipher the potential underlying mechanism of LBP. Methods. Female C57BL/6J mice were fed a control diet, HFD, or 150 mg/kg LBP‐supplemented HFD for 6 weeks before conception and throughout gestation. Oral glucose tolerance test and plasma lipid levels were determined, and liver histopathology was assessed. Sequencing was used to define the microRNA expression profiling of plasma exosomes in the three groups of mice, and protein expression levels of the candidate target genes were analyzed. Results. LBP significantly relieved glucose intolerance, abnormal plasma lipid levels, and pathomorphological changes of liver histopathology in HFD‐induced GDM mice. Moreover, we found that this effect of LBP was mediated by downregulation of the increase of 6 miRNAs (miR‐93‐3p, miR‐188‐5p, miR‐466k, miR‐1188‐5p, miR‐7001‐3p, and miR‐7115‐5p) and reversing the increase of the protein expression of CPT1A, which is the target gene of miR‐188‐5p. Conclusions. Our findings provide novel insights into the biological activities of LBP in the treatment of GDM.
- 1 January 2020
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2020 (1) , 2953502
Open AccessExosomal MicroRNA Expression Profiling Analysis of the Effects of Lycium Barbarum Polysaccharide on Gestational Diabetes Mellitus Mice
Objective. Gestational diabetes mellitus (GDM) is a pathological condition, affecting an increasing number of pregnant women worldwide. Safe and effective treatment for GDM is very important for the public health. In this study, we utilized a high‐fat diet‐induced GDM model to evaluate the effects of LBP on GDM and examined the changes of exosomal microRNA expression profiling to decipher the potential underlying mechanism of LBP. Methods. Female C57BL/6J mice were fed a control diet, HFD, or 150 mg/kg LBP‐supplemented HFD for 6 weeks before conception and throughout gestation. Oral glucose tolerance test and plasma lipid levels were determined, and liver histopathology was assessed. Sequencing was used to define the microRNA expression profiling of plasma exosomes in the three groups of mice, and protein expression levels of the candidate target genes were analyzed. Results. LBP significantly relieved glucose intolerance, abnormal plasma lipid levels, and pathomorphological changes of liver histopathology in HFD‐induced GDM mice. Moreover, we found that this effect of LBP was mediated by downregulation of the increase of 6 miRNAs (miR‐93‐3p, miR‐188‐5p, miR‐466k, miR‐1188‐5p, miR‐7001‐3p, and miR‐7115‐5p) and reversing the increase of the protein expression of CPT1A, which is the target gene of miR‐188‐5p. Conclusions. Our findings provide novel insights into the biological activities of LBP in the treatment of GDM.